Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-03-19
1996-01-09
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, 514422, 540596, 546202, 548525, A61K 31445, C07D40910
Patent
active
054829496
ABSTRACT:
The present invention relates to sulfonate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.
REFERENCES:
patent: 4133814 (1979-01-01), Jones et al.
patent: 4418068 (1983-11-01), Jones
patent: 4729999 (1988-03-01), Young
patent: 4894373 (1990-01-01), Young
patent: 4970237 (1990-11-01), Jensen et al.
U.S. application Ser. No. 07/920,933 Black, et al. Aug. 28, 1992.
U.S. application Ser. No. 07/995,222 Black, et al. Dec. 22, 1992.
Williams, et al., Journal of Bone and Mineral Research, 6 (1991).
FDC Reports, T&G 11, Mar. 30, 1992.
Jones, et al., J. Med. Chem., 27, 1057-1066 (1984).
Feldmann, et al., Bone and Mineral, 7, 245-254 (1989).
"Tamoxifen Trial Restricted", SCRIP No. 1702 Mar. 20, 1992, p. 22.
Jordan, et al., Breast Cancer Research Treatment, 10: 31-35 (1987).
Beall, et al., Calcif Tissue Int., 36: 123-125 (1984).
Turner, et al., Journal of Bone and Mineral Research, 2, No. 5, 449-456 (1987).
Williams, et al., Bone and Mineral, 14, 205-220 (1991).
Turner, et al., Endocrinology, 122, No. 3, 1146-1150 (1988).
Love, et al., The New England Journal of Medicine, 326, No. 13, 852-856 (1992).
Breckenridge, et al., Lipids, 22, No. 7, 505-512 (1987).
Lazier, et al., Biochem. Cell Biol., 68, 210-217 (1990).
Lobo, J. Clin. Endocrinol. Metab., 73, No. 5, 925-930 (1991).
Love, et al., Ann. Intern. Med., 115, No. 11, 860-864 (1991).
Walsh, et al., N. Engl. J. Med., 325, No. 17, 1196-1204 (1991).
Bagdade, et al., J. Clin. Endocrinol. Metab., 70, No. 4, 1132-1135 (1990).
Love, et al., J. Natl. Cancer Inst., 82, No. 16, 1327-1332 (1990).
Teo, et al., J. Med. Chem., 35, 1330-1339 (1992).
Cypriani, et al., J. Steroid Biochem., 31, No. 5, 763-771 (1988).
Cypriani, et al., Chemical Abstracts, CA 110: 1189 v, 1989.
Cypriani, et al., Chemical Abstracts, 110:69550v, 1989.
American Chemical Society, Registry, RN#63676-25-5 1989.
Bundgaard, H. "Design of prodrugs" Elsevier Publishing, pp. 1-10, ((1985).
Black Larry J.
Bryant Henry U.
Cullinan George J.
Chang Ceila
Demeter John C.
Eli Lilly and Company
Sales James J.
LandOfFree
Sulfonate derivatives of 3-aroylbenzo[b]thiophenes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfonate derivatives of 3-aroylbenzo[b]thiophenes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonate derivatives of 3-aroylbenzo[b]thiophenes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1303331